The National Family Health Survey (NFHS-6) is far more than a public health report—it is one of India's most important strategic documents for healthcare leaders, investors, entrepreneurs and policymakers.

In this episode of Healthcare India, Dr. Vikram Venkateswaran analyses the latest NFHS-6 findings through the lens of healthcare strategy and explores how India's changing demographics will reshape healthcare delivery over the next decade.

Key topics include:

• Why India's ageing population will redefine healthcare demand
• The rapid rise of digital health readiness
• How health insurance is transforming healthcare economics
• Why healthcare must evolve from episodic treatment to continuous care
• The growing importance of AI, home healthcare and integrated care platforms
• Three bold predictions for Indian healthcare in 2035

If you are a healthcare CEO, founder, investor, clinician or policymaker, this episode provides strategic insights into where India's healthcare system is heading—and how organisations can prepare for the future.

In this episode, I speak with Akshay Verma, CEO & Founder of Fitpass, about the future of corporate wellness in India.

We explore how fitness behaviour is shifting across demographics and geographies, with surprising trends emerging in Tier 2 cities and among women who are adopting diverse workout formats.

The conversation also examines why corporate wellness programs are failing to create real impact, especially for India’s young workforce, and what needs to change.

We discuss:

• Behavioural vs. cultural vs infrastructure barriers to fitness
• India’s growing metabolic health crisis
• Data-backed insights on participation across age and gender
• Unexpected findings, including Agra’s rise as a highly active city

A sharp, data-driven conversation for leaders rethinking health, productivity, and workforce well-being.

The Manipal Health Enterprises IPO marks a shift in Indian healthcare—from expansion to efficiency.

In this episode, we break down what investors often miss:
This is not a turnaround or margin expansion play. Manipal is already operating at ~25–27% EBITDA margins and ~65–67% occupancy, with a ₹9,000 crore scale.

So what’s the real bet?

We explore:

Why this IPO is about sustaining excellence, not chasing growthThe true drivers of valuation: ARPOB, case mix, capital disciplineA realistic ₹45,000–₹60,000 crore valuation lensKey risks: doctor dependency, pricing pressure, integration complexity

If you’re looking beyond headlines to fundamentals, this episode will reframe the way you evaluate hospital IPOs.

This is not a bet on demand. It’s a bet on execution.

India’s Digital Personal Data Protection Act (DPDPA) is set to fundamentally reshape how healthcare organisations collect, store, and use patient data.

In this episode of the Healthcare India Podcast, we unpack what the law really means for hospitals, digital health platforms, diagnostic chains, and health-tech startups.

While most conversations focus on compliance checklists, this discussion goes deeper—examining the strategic, operational, and technological implications of the law.

Key topics discussed include:

• Why healthcare organisations will likely be classified as Significant Data Fiduciaries (SDFs)
• The reality of 72-hour breach notification in complex hospital environments
• How consent management will disrupt traditional Hospital Information Systems (HIS) and Electronic Health Records (EHR) workflows
• The role of Security Operations Centres (SOC), SIEM monitoring, and RBAC security architecture
• Cross-border data transfer challenges for global healthcare companies operating in India
• The operational impact of patient rights — erasure, portability, and correction
• Why compliance cannot be treated as “paper compliance” and requires executive oversight

We also discuss how healthcare leaders should sequence implementation over the next 18 months, beginning with data mapping and governance before building consent infrastructure and appointing a Data Protection Officer.

If you are a healthcare founder, hospital executive, digital health entrepreneur, or investor trying to understand the future of patient data governance in India, this episode provides a practical roadmap for navigating the coming regulatory shift.

AI is no longer theoretical in Indian healthcare — but it is far from autonomous.

In this episode, we examine how India is moving from AI hype to hospital reality. The discussion covers regulatory risk appetite, fragmented data systems, interoperability challenges, ethical accountability, and the practical business barriers slowing adoption.

We highlight where AI is already showing promise — operational optimization, diagnostic triage, chronic disease pathways, and public health screening — and why assistive AI will dominate over the next 3–5 years.

The core insight: India doesn’t lack algorithms. It needs better data hygiene, validation frameworks, and workflow-native deployment models.

For healthcare leaders, startup founders, regulators, and investors navigating India’s AI transition — this episode offers a grounded, strategic perspective on what will scale and what won’t.

When private equity evaluates a hospital group, what truly moves the EBITDA multiple — and what is just digital theatre?

In this episode, we go deep with Arvind Sivaramakrishnan, CTO for Asia Healthcare Holdings ,into how investors assess technology maturity during healthcare diligence. We unpack the difference between hygiene technologies and valuation-accelerating capabilities, and examine how digital infrastructure now influences deal outcomes.

We discuss:

• Which tech capabilities tangibly improve valuation multiples

• How investors assess data maturity, interoperability, and cyber risk

• Why automation is becoming a margin stabiliser

• The linkage between clinical improvement and enterprise value

• The technologies likely to command a premium by 2030

If you are a CEO, CTO, founder, or healthcare investor, this conversation reframes digital strategy as an investment thesis — not an IT roadmap.

What does longevity look like when it’s designed for millions—not just a few?

In this episode, Kristy Berry, CEO of Cenegenics, joins Dr Vikram Venkateswaran on the Healthcare India Podcast to discuss healthspan, behaviour change, data realism, and why longevity must evolve into a scalable platform.

From India’s early chronic disease burden to the ethics of access and trust, the conversation also uncovers an unexpected insight: the spiritual and purpose-driven side of living well, longer.

What happens when five decades of unexplained symptoms collide with the limits of modern medicine?

In this episode of the Healthcare India Podcast, Dr Vikram Venkateswaran speaks with Haresh Patel—entrepreneur, systems thinker, and author of The Ghost in My Body. What begins as a conversation about diagnostic failure, fragmented data, and the blind spots of specialisation evolves into something far deeper.

Drawing on his lived experience of seeing more than a dozen specialists over fifty years, Haresh reframes illness not as a single-diagnosis problem, but as a systems failure—one that medicine is not structurally designed to solve. The discussion explores why healthcare rewards specialisation over synthesis, how longitudinal data and pattern recognition are consistently underused, and why AI must augment—not replace—human intuition.

Unexpectedly, the conversation takes a spiritual turn. Beyond data, technology, and architecture, Dr Vikram finds himself confronting a dimension he did not anticipate—where meaning, awareness, and the human search for coherence intersect with clinical science. The “ghost” turns out to be not just in the body, but in how we understand healing itself.

This episode will resonate with clinicians, founders, technologists, and anyone questioning whether the future of diagnosis lies only in better tools—or in deeper insight.
A conversation that starts with systems thinking and ends by challenging how we define health, certainty, and care.